Biologics

Biologics Market Research Report: Forecast (2021-2026)

By Therapeutic Application (Oncology, Infectious Disease, Autoimmune Disease, Diabetes, Metabolic disorders, Inflammatory Bowel Diseases, Respiratory Disorders, Neurological Disorders, Cardiovascular Read more

  • Healthcare
  • Jul 2021
  • 197
  • HC55023

Market Overview

Biologics are drugs derived from living organisms or comprised of components of a living organism. It is available in the form of genetically engineered proteins. These drugs help in the treatment of chronic diseases, including cancer, neurology, and cardiovascular disorders.

According to MarkNtel Advisors’ research report, “Global Biologics Market Analysis, 2021,” the market is likely to grow at a CAGR of around 9% during 2021-26. The growth of the Biologics market is associated with several factors, such as the surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients. Other factors driving the demand for biologics in the market include monoclonal antibodies for disease treatment and innovation & advancement in the healthcare & biotechnology sectors. Moreover, regulatory approval from the governments in different countries is also contributing to the growth of the Biologics market. 

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
CAGR (2021-2026) 9%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy
Asia-Pacific: China, India, Japan, South Korea, Australia 
South America: Brazil, and Argentina
Middle East & Africa: UAE, Saudi Arabia, South Africa
Key Companies Profiled Abbive Inc., Amgen Inc., F. Hoffman La Roche, Samsung Electronics, Merck & Co., AstraZeneca Plc, Bristol-Myers Squibb, Novartis, Pfizer, Sanofi
Unit Denominations USD Million/Billion

 

COVID-19 Pandemic Positively Impacted the Market Growth

The impact of COVID-19 has been leading to numerous research initiatives in biologics to find a suitable cure. Due to the pandemic, the global investments in biologics increased due to continuous demand for producing small molecule drugs. Thus, with the increasing number of COVID-19 cases, the need for biologics increased significantly. All the postponed treatments and consultations resumed in the last few months of 2020, which has resulted in aiding the number of treatment procedures using biologics. Hence, the Global Biologics Market is very likely to witness a significant surge in its growth rate in the forthcoming timeframe.

Biologics Market Research Report: Forecast (2021-2026)

Market Segmentation

Vaccine Segment Accounted for the Largest Market Share

Based on the Product/Drug Class, the market bifurcates into Recombinant therapeutic Products, Monoclonal Antibodies, Hormones, Cytokines, Enzymes, Blood & Blood Components, Cellular & Gene Therapy, Vaccines, and Oligonucleotides. The vaccines segment acquired a considerable market share in the Global Biologics Market in the previous few years. The segment growth owes to the increasing government & non-government initiatives for vaccine R&D activities and the prevention of various infectious diseases. Moreover, the development of bivalent & pentavalent vaccines that can prevent an individual from more than one disease worldwide is another factor likely to fuel the segment growth, cites MarkNtel Advisors in their research report, “Global Biologics Market Analysis, 2021.”

In-House Segment Dominated the Market 

Based on Manufacturing Type, the market classifies into Outsource and In-house segments. Here, In-house manufacturing bagged the largest share in the Global Biologics Market in the previous few years. It owes to numerous companies opting for in-house manufacturing than to purchase the entity or outsource it entwined with the massive investments made by CMO’s for mushrooming commercial biopharmaceutical manufacturing capacity. However, the outsourcing segment is likely to showcase a gradual increase in demand in the coming years.

Regional Landscape

North America Region Attained the Highest Market Share

Geographically, North America held the largest market share in the Global Biologics Market in the previous few years. It owes to the spurring approvals in the US comprising larger patent protection than that in the European region. North America also witnessed the most prominent corona fatalities than other regions across the globe. This grim societal scenario is pushing the pharmaceutical giants to invest in biologics in cohesion with the governments. Other factors fueling the market growth in the region are growing diabetes patients, a surging aging population, and the availability of several research centers.

Market Driver

Spurring Demand for Biologics in Treatment of Chronic Diseases

Biologics are used profoundly for providing effective treatment for many complex diseases, such as rheumatoid arthritis and psoriasis, which have limited treatment options. With the advent of technology and innovation in the healthcare sector, there has been a significant escalation in amenities & equipment for rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs. The key biologics used for treating rheumatoid arthritis are Adalimumab (HumiraInfliximab (Remicade), Anakinra (Kineret), Abatacept (Orencia), and Rituximab (Rituxan).

Market Challenge

Limitations in Production of Access Capacity

A successful product launch of biologics drugs needs a very long time for performing research and development activities. It also requires massive capital investments. In addition to this, the production of biological drugs is a complex procedure, and stringent government regulations often delay the same. Hence, these factors restrain the growth of the Biologics market across the globe to a certain extent.

Competitive Landscape

According to MarkNtel Advisors, the major leading players in the Global Biologics Market are Abbive Inc., Amgen Inc., F. Hoffman La Roche, Samsung Electronics, Merck & Co., AstraZeneca Plc., Bristol-Myers Squibb, Novartis, Pfizer, and Sanofi.

Key Questions Answered in the Market Research Report:

  1. What are the overall market statistics or estimates (Market Overview, Market Size- by Value, Forecast Numbers, Market Segmentation, and Market Shares) of the Global Biologics Market?
  2. What are the region-wise industry size, growth drivers, and challenges?
  3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Biologics Market? 
  4. Who are the key competitors, their key strengths & weaknesses, and how they perform in the Global Biologics Market based on a competitive benchmarking matrix?
  5. What are the key results derived from the market surveys conducted during the Global Biologics Market study?   

Market Outlook, Segmentation, and Statistics 

  • Impact of COVID-19 on Global Biologics Market
  • Market Size & Analysis
    • By Value
    • By Volume
  • Market Share & Analysis
    • By Therapeutic Application 
      • Oncology
      • Infectious Disease
      • Autoimmune Disease
      • Diabetes
      • Metabolic disorders
      • Inflammatory Bowel Diseases 
      • Respiratory Disorders
      • Neurological Disorders
      • Cardiovascular Disorder
      • Musculoskeletal Disorders
      • Ophthalmic Disorders
      • Others
    • By Distribution channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Manufacturing
      • Outsource
      • In-house
    • By Product/Drug Class
      • Recombinant therapeutic Products
      • Monoclonal Antibodies
      • Hormones
      • Cytokines
      • Enzymes
      • Blood and Blood Components
      • Cellular and Gene Therapy
      • Vaccines
      • Oligonucleotides
    • By Region
      • North America
      • South America
      • Europe
      • Middle East & Africa
      • Asia-Pacific
    • By Competitors
      • Competition Characteristics
      • Market Share & Analysis
      • Competitive Matrix
  • Global Biologics Market Hotspots & Opportunities
  • Global Biologics Market Regulations & Policy
  • Key Strategic Imperatives for Success and Growth
  • Global Competition Outlook
    • Competition Matrix
    • Company Profile

Frequently Asked Questions

A. The Global Biologics Market is forecast to grow at a CAGR of 9% during 2021-26.

A. Abbive Inc., Amgen Inc., F. Hoffman La Roche, Samsung Electronics, Merck & Co., AstraZeneca Plc., Bristol-Myers Squibb, Novartis, Pfizer, and Sanofi are a few of the leading players in the Global Biologics Market.

A. The Vaccine is likely to attain the highest CAGR during the forecast period and maintain its significant market share.

A. North America continues to grow at the highest CAGR during 2021-26, thereby presenting immense opportunities to market players of the Global Biologics Market.

A. Burgeoning prevalence of chronic diseases, increasing research and development activities, rising investment for the development of biologics, the surge in healthcare spending, and a hike in the sedentary lifestyles of individuals are the prime factors backing the market growth.

A. Due to the Covid-19 pandemic, the global investments in biologics increased due to continuous demand for the production of small molecule drugs. Thus, with the increasing number of COVID-19 cases, the need for biologics increased significantly during the pandemic.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Glossary
    4. Market Segmentation
  2. Executive Summary
  3. Expert Verbatim- Interview Excerpts of 10 industry experts
  4. Impact of COVID-19 on Global Biologics Market
  5. Global Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic Application
        1. Oncology
        2. Infectious Disease
        3. Autoimmune Disease
        4. Diabetes
        5. Metabolic disorders
        6. Inflammatory Bowel Diseases
        7. Respiratory Disorders
        8. Neurological Disorders
        9. Cardiovascular Disorder
        10. Musculoskeletal Disorders
        11. Ophthalmic Disorders
        12. Others
      2. By Distribution channel
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      3. By Manufacturing
        1. Outsource
        2. In-house
      4. By Product/Drug Class
        1. Recombinant therapeutic Products
          1. Monoclonal Antibodies
          2. Hormones
          3. Cytokines
          4. Enzymes
        2. Blood and Blood Components
        3. Cellular and Gene Therapy
        4. Vaccines
        5. Oligonucleotides
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. Asia-Pacific
        5. Middle East & Africa
      6. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
  6. North America Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
      5. By Country
        1. US
        2. Canada
        3. Mexico
    3. US Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    4.  Canada Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    5. Mexico Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
  7. South America Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
      5. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Brazil Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    4. Argentina Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
  8. Europe Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
      5. By Country
        1. The UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Others
    3. UK Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    4. Germany Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    5. France Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    6. Italy Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
    7. Spain Biologics Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Therapeutic application
        2. By Distribution Channel
        3. By Manufacturing
        4. By Product/Drug Class
  9. Asia-Pacific Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
  10. Market Share & Analysis
    1. By Therapeutic application
    2. By Distribution Channel
    3. By Manufacturing
    4. By Product/Drug Class
    5. By Country
      1. China
      2. India
      3. Japan
      4. Australia
      5. South Korea
      6. Others
  11. China Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  12. India Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  13. Japan Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  14. Australia Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  15. South Korea Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  16. Middle East and Africa Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
      5. By Country
        1. UAE
        2. Saudi Arabia
        3. Others
  17. UAE Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  18. Saudi Arabia Biologics Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Therapeutic application
      2. By Distribution Channel
      3. By Manufacturing
      4. By Product/Drug Class
  19. Global Biologics Dynamics
    1. Drivers
    2. Challenges
    3. Impact Analysis
  20. Global Biologics Regulations, Product Standards
  21. Global Biologics Intellectual Property Rights Analysis
  22. Global Biologics Hotspots & Opportunities
  23. Competition Outlook
    1. Competitor Wise Growth Strategies
      1. Product Portfolio
      2. Brand Specialization
      3. Target Markets
      4. Research & Development
      5. Strategic Alliances & Initiatives
    2. Company Profiles
      1. Abbive Inc.
      2. Amgen Inc.
      3. F. Hoffman La Roche
      4. Samsung Electronics
      5. Merck & Co.
      6. AstraZenca Plc.
      7. Bristol-Myers Squibb
      8. Novartis
      9. Pfizer
      10. Sanofi
  24. Disclaimer
Global Biologics Market Segmentation